Đang chuẩn bị liên kết để tải về tài liệu:
Treatment of gastric peritoneal carcinomatosis by combining complete surgical resection of lesions and intraperitoneal immunotherapy using catumaxomab

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

The peritoneum is one of the most frequent sites of recurrent gastric carcinoma after curative treatment, despite the administration of pre- and/or postoperative systemic chemotherapy. Indeed, the prognosis of peritoneal carcinomatosis from gastric carcinoma continues to be poor, with a median survival of less than one year with systemic chemotherapy. |

TÀI LIỆU LIÊN QUAN

Increased risk of gastric adenocarcinoma after treatment of primary gastric diffuse large B-cell lymphoma

Surgical treatment results of gastric cancer in the lower third of the stomach

Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: A propensity score-matched analysis

Early outcomes of surgical treatment with perioperative chemotherapy for gastric cancer

Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): A phase II study (GASPAR)

Clinical and paraclinical characteristics of locally advanced distal gastric adenocarcinoma patients underwent the treatment of postoperative adjuvant chemoradiotherapy at Hue Central Hospital

Cytoreductive surgery and Hyperthermic intra-operative peritoneal chemotherapy with Cisplatin for gastric peritoneal Carcinomatosis Monocentric phase-2 nonrandomized prospective clinical trial

A multi-center phase II study and biomarker analysis of combined cetuximab and modified FOLFIRI as second-line treatment in patients with metastatic gastric cancer

Effects for sequential treatment of siAkt and paclitaxel on gastric cancer cell lines

Waiting time for cancer treatment and mental health among patients with newly diagnosed esophageal or gastric cancer: A nationwide cohort study
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.